Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which engages in the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. Its business includes product pipeline, R&D platform, and business development. The company was founded by Youzhi Tong and Chuangxing Guo on March 24, 2009, and is headquartered in Suzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company